Valuation: AstraZeneca PLC

Market Cap 246B 220B 205B 186B 351B 23,833B 353B 2,462B 965B 12,151B 925B 905B 38,992B P/E 2026 *
20.6x
P/E 2027 * 17.6x
Enterprise Value 266B 238B 221B 201B 380B 25,773B 382B 2,663B 1,043B 13,140B 1,000B 978B 42,166B EV / Sales 2026 *
4.22x
EV / Sales 2027 * 3.86x
Free-Float
96.62%
Yield 2026 *
2.1%
Yield 2027 * 2.23%
1 day+1.08%
1 week+1.11%
Current month-2.57%
1 month+4.77%
3 months-6.98%
6 months-16.15%
Current year-6.57%
1 week 1,556
Extreme 1556
1,610
1 month 1,535.5
Extreme 1535.5
1,689
Current year 1,467
Extreme 1467
1,925.5
1 year 1,467
Extreme 1467
1,925.5
3 years 1,226
Extreme 1226
1,925.5
5 years 978.1
Extreme 978.1
1,925.5
10 years 461.3
Extreme 461.3
1,925.5
Manager TitleAgeSince
Chief Executive Officer 66 30/09/2012
Director of Finance/CFO 52 31/07/2021
Chief Operating Officer 55 31/05/2015
Director TitleAgeSince
Director/Board Member 70 05/04/1999
Director/Board Member 66 30/09/2012
Director/Board Member 65 26/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%+1.11% - - 246B
+0.83%+3.19%+37.87%+106.25% 1,051B
+1.93%+2.11%+36.82%+64.90% 630B
+1.49%+5.19%+19.84%+85.41% 489B
+2.26%+0.90%+66.40%+39.33% 359B
+1.45%+3.50%+21.87%+42.64% 344B
+1.17%+2.37%+11.71%+35.14% 272B
+0.89%+1.08%-7.28%+10.52% 246B
+1.82%+2.94%+40.43%+52.78% 224B
+2.77%+4.44%+29.49%+101.40% 187B
Average +1.46%+2.53%+28.57%+59.82% 422.63B
Weighted average by Cap. +1.19%+2.44%+31.57%+69.97%

Financials

2026 *2027 *
Net sales 63.17B 56.42B 52.48B 47.74B 90.14B 6,114B 90.53B 632B 248B 3,117B 237B 232B 10,003B 67.05B 59.88B 55.71B 50.67B 95.67B 6,489B 96.08B 670B 263B 3,308B 252B 246B 10,617B
Net income 11.9B 10.63B 9.89B 8.99B 16.98B 1,152B 17.05B 119B 46.62B 587B 44.69B 43.71B 1,884B 13.84B 12.36B 11.5B 10.46B 19.74B 1,339B 19.83B 138B 54.21B 683B 51.96B 50.83B 2,191B
Net Debt 20.05B 17.9B 16.65B 15.15B 28.6B 1,940B 28.72B 200B 78.54B 989B 75.27B 73.63B 3,174B 12.38B 11.05B 10.28B 9.35B 17.66B 1,198B 17.73B 124B 48.48B 611B 46.47B 45.45B 1,959B
Projected Income Statement - Annual - AstraZeneca PLC
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
09/10/26 SEK 1,591.50 +1.08% 435,386
08/10/26 SEK 1,574.50 -2.20% 419,438
07/10/26 SEK 1,610.00 +1.67% 374,867
06/10/26 SEK 1,583.50 +1.51% 480,711
05/10/26 SEK 1,560.00 -0.89% 356,679
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - AstraZeneca PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
158.77USD
Average target price
209.08USD
Spread / Average Target
+31.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AstraZeneca PLC